文献速递儿童呼吸儿童神经与发育行为

基于接纳承诺疗法的育儿项目在哮喘共病ADHD儿童中的随机临床试验

Acceptance and Commitment Therapy-Based Parenting Program in Children With Co-Occurring Asthma and ADHD: A Randomized Clinical Trial.
PubMed 文献 · JAMA Pediatr · 2025-01-01

该评估者盲法随机临床试验纳入118对哮喘共病ADHD的亲子,比较ACT-PAM联合标准哮喘照护与单独标准照护,随访12个月。结果显示联合组非计划就诊减少、哮喘控制改善、ADHD症状减轻,父母心理灵活性与哮喘管理自我效能亦改善。

要点

  • ACT-PAM联合标准照护较单独标准照护12个月内非计划就诊调整均值差为-0.8次(95%CI -1.6至-0.1)。
  • C-ACT评分改善调整均值差4.4(95%CI 2.5-6.5;Cohen d 1.40)。
  • 父母心理不灵活性与哮喘管理自我效能均获改善。

核心结论

  • ACT-PAM可减少哮喘共病ADHD儿童的医疗使用、改善哮喘控制并减轻ADHD症状。

研究设计与样本

  • 评估者盲法随机临床试验,2021年4月1日至2023年8月31日在香港一家公立医院开展。
  • 纳入118名哮喘共病ADHD儿童的父母,随机接受ACT-PAM联合标准哮喘照护(TAU)或单独TAU。
  • ACT-PAM为6次团体课程,聚焦接纳、正念、价值导向育儿与哮喘管理。
  • 采用意向性治疗原则分析,随访至干预后12个月。

主要发现

  • 12个月内非计划就诊调整均值差为-0.8次(95%CI -1.6至-0.1;调整发生率比0.33,95%CI 0.19-0.55)。
  • C-ACT评分调整均值差4.4(95%CI 2.5-6.5;Cohen d 1.40,95%CI 1.10-1.79)。
  • 父母评定SWAN合并分调整均值差-0.5(95%CI -0.8至-0.3;Cohen d -0.94,95%CI -1.32至-0.56)。
  • 父母心理不灵活性调整均值差-10.0(95%CI -15.6至-4.5;Cohen d -1.08,95%CI -1.47至-0.69)。
  • 哮喘管理自我效能调整均值差0.8(95%CI 0.4-1.2;Cohen d 1.20,95%CI 0.78-1.68)。

关键数值与推荐

  • 主要结局为12个月内哮喘急性发作的非计划医疗就诊次数。
  • 次要结局包括C-ACT哮喘控制、SWAN父母评定ADHD症状、父母心理不灵活性与哮喘管理自我效能。

临床怎么用

  • 对哮喘共病ADHD儿童,可在标准哮喘照护基础上联用ACT-PAM以降低非计划就诊并改善哮喘控制与ADHD症状。
  • ACT-PAM为6次团体课程,内容涵盖接纳、正念、价值导向育儿与哮喘管理,可供临床借鉴。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Co-occurring asthma and attention-deficit/hyperactivity disorder (ADHD) in children increase caregiving complexity and health care use, underscoring the need for holistic interventions addressing both conditions. OBJECTIVE: To examine the efficacy of an acceptance and commitment therapy-based parenting program (ACT-PAM) on health outcomes in children with asthma and ADHD and their parents over 12 months postintervention. DESIGN, SETTING, AND PARTICIPANTS: This assessor-blinded randomized clinical trial was conducted from April 1, 2021, to August 31, 2023, at a Hong Kong public hospital and enrolled 118 parents of children with asthma and comorbid ADHD. Participants were randomized to receive either ACT-PAM plus standard asthma care as treatment as usual (TAU) or TAU alone. Data were analyzed from December 1, 2023, to March 31, 2024, using an intention-to-treat principle. INTERVENTIONS: Six ACT-PAM group sessions focused on acceptance, mindfulness, values-based parenting, and asthma management. MAIN OUTCOMES AND MEASURES: The primary outcome was the number of unscheduled health care visits for asthma exacerbations over 12 months. Secondary outcomes included asthma control (via the Childhood Asthma Control Test [C-ACT]), ADHD symptoms in children (via parent-rated scores on Strengths and Weaknesses of ADHD Symptoms and Normal Behaviors [SWAN] scale), parental psychological inflexibility, and asthma management self-efficacy. RESULTS: Among 118 parent-child dyads (mean [SD] parent age, 40.3 [5.5] years; mean [SD] child age, 7.9 [2.2] years; 108 female parents [92%] and 31 female children [26%]), ACT-PAM plus TAU significantly reduced unscheduled health care visits compared with TAU alone (adjusted mean difference [aMD], -0.8 visits; 95% CI, -1.6 to -0.1; adjusted incidence rate ratio, 0.33; 95% CI, 0.19-0.55). C-ACT scores improved (aMD, 4.4; 95% CI, 2.5-6.5; Cohen d, 1.40; 95% CI, 1.10-1.79), while parent-rated SWAN combined scores decreased (aMD, -0.5; 95% CI, -0.8 to -0.3; Cohen d, -0.94; 95% CI, -1.32 to -0.56). Parental psychological inflexibility (aMD, -10.0; 95% CI, -15.6 to -4.5; Cohen d, -1.08; 95% CI, -1.47 to -0.69) and asthma management self-efficacy (aMD, 0.8; 95% CI, 0.4-1.2; Cohen d, 1.20; 95% CI, 0.78-1.68) were also improved with the combination of ACT-PAM and TAU. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, ACT-PAM reduced health care use, improved asthma control, and alleviated ADHD symptoms, demonstrating its efficacy in managing pediatric asthma with comorbid ADHD. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04991649.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Chong YY, Chien WT, Fung KP, et al. Acceptance and Commitment Therapy-Based Parenting Program in Children With Co-Occurring Asthma and ADHD: A Randomized Clinical Trial. JAMA Pediatr. 2025. PMID: 40455452. doi:10.1001/jamapediatrics.2025.1313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。